Title | Signal transduction differences between WT and polymorphic α2Β-adrenergic receptor in LLC-PK1 Cells | |
Authors | Orthodoxia Mastrogianni¹, George Karkoulias¹, Herve Paris² and Christodoulos Flordellis¹
1. Department of Pharmacology, School of Medicine, University of Patras, 26110 Rio Patras, Greece 2. INSERM U388, Institut Louis Bugnard, CHU Rangueil, Toulouse, France |
|
Citation | Mastrogianni, Ο., Karkoulias, Γ., Paris, Η., Flordellis, Ch: Signal transduction differences between WT and polymorphic α2Β-adrenergic receptor in LLC-PK1 Cells, Epitheorese Klin. Farmakol. Farmakokinet. 20(2): 249-250 (2006) | |
Publication Date | Accepted for publication: 19-20 May 2006 | |
Full Text Language | English | |
Order – Buy | Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €)
pharmakonpress[at]pharmakonpress[.]gr |
|
Keywords | α2Β-adrenergic receptor, MAPK, Akt, NF-κB, IKKα/β. | |
Other Terms | review article | |
Summary | The aim of the present study was to characterise the signaling pathway triggered by activated human α2B-adrenergic receptor in trasfected LLC-PK1, a renal tubular cell line. Moreover to investigate differences between the wild-type (WT) and a polymorphic α2B-AR (MUT), which has a deletion of three glutamic acids (Del301-303) in its third intracellular loop. Upon agonist stimulation with UK 14304, both receptors (WT and MUT) induced ERK1/2 phosphorylation, whilst this phosphorylation was abolished by prior treatment of the cells with LY 240092, a pharmacological inhibitor of PI3K. Treatment of the cells with UK 14304 induced IKK phosphorylation and NF-KB-driven luciferase activity and this activation was abolished by prior treatment of the cells with LY 240092. The activation of IKK/NF-κB from the polymorphic adrenoceptor was absolutely dependent on prior ERK activation, in clear demarcation to WT-induced NF-κB activation, which is ERK independent. | |
References | 1. MacDonald E., Kobilka B.K., Scheinin M.: Trends Pharmacol. Sci. 18: 211 (1997)
2. Makaritsis K.P., Handy D.E., Johns C., Kobilka B., Gavras I., Gavras H.: Hypertension 33: 14 (1999) 3. Small K.M., Brown K.M., Forbes S.L., Liggett S.B.: J Biol Chem. 276: 4917 (2001) 4. Flordellis C.S., Berguerand M., Gouache P., Barbu V., Gavras H., Handy D.E., Bereziat G., Masliah J.: J. Biol. Chem. 270: 3491 (1995) 5. Liu A.M., Wong Y.H.: J. Biol. Chem. 279: 53196 (2004) 6. Cussac D., Schaak S., Denis C., Paris H.: J. Biol. Chem. 277: 19882 (2002) 7. Flordellis C., Manolis A., Scheinin M., Paris H.: Int. J. Cardiol. 97: 367 (2004) |
|
Relative Papers |
Online ISSN 1011-6575
Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:
- Chemical Abstracts
- Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor
Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor
Συντακτικη Επιτροπή-Editorial Board
ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2006 – ANNUAL SUBSCRIPTION 2006 | |
Γλώσσα Πλήρους Κειμένου – Full Text Language | Αγγλικά – English |
Παραγγελία – Αγορά – Order – Buy | Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)
pharmakonpress[at]pharmakonpress[.]gr |
Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)
pharmakonpress[at]pharmakonpress[.]gr |